Adamantane derivatives
CA 2393352 C · Owner: Alcaraz, Lilian · Inventors: Pimm, Austen; Luker, Timothy; Mortimore, Michael
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides adamantane derivatives of formula (I) a process for , their preparation, pharmaceutical compositions containing them a process for , preparing the pharmaceutical compositions and their use in therapy. In , formula (I) D represents CH2 or CH2CH2 E represents C(O)NH or NHC(O) and R3 , represents a group of formula (I).
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 12, 2000 and granted August 30, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 12, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 12, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.